Novartis’ Multiple Sclerosis Pill Faces FDA Review (Update1)

Status
Not open for further replies.

guest

🐐 Untouchable Legend
Dec 30, 2008
14,802
0
811
Novartis AG's drug Gilenia has risks that may outweigh its benefit in treating multiple sclerosis, according to U.S. regulators reviewing whether to approve the first pill to slow progression of the disease.


More...

Toggle signature
||||| Mentor Group Access Now! |||||
 
Status
Not open for further replies.

JohnnyDoe.is is an uncensored discussion forum
focused on free speech,
independent thinking, and controversial ideas.
Everyone is responsible for their own words.

Quick Navigation

User Menu